Cargando…

Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on (18)F-FDG PET-CT in Patients with Follicular Lymphoma

PURPOSE: The purpose of this study was to investigate the prognostic significance of total metabolic tumor volume (TMTV) and total lesion glycolysis (TLG) in patients with follicular lymphoma (FL) at baseline and mid-treatment with (18)F-fluorodeoxyglucose positron emission tomography-computed tomog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jin-Hua, Zhang, Yun-Ping, Xia, Jun, Ding, Chong-Yang, Wu, Wei, Wang, Li, Cao, Lei, Zhu, Hua-Yuan, Fan, Lei, Li, Tian-Nv, Li, Jian-Yong, Xu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790864/ https://www.ncbi.nlm.nih.gov/pubmed/30913868 http://dx.doi.org/10.4143/crt.2018.649

Ejemplares similares

Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on (18)F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma
por: Feng, Xiaoyan, et al.
Publicado: (2021)

Prognostic values of baseline, interim and end-of therapy (18)F-FDG PET/CT in patients with follicular lymphoma
por: Zhou, Yeye, et al.
Publicado: (2019)

The prognostic role of 18F-FDG PET/CT baseline quantitative metabolic parameters in peripheral T-cell lymphoma
por: Xia, Jun, et al.
Publicado: (2019)

Prognostic value of baseline total metabolic tumour volume of (18)F-FDG PET/CT imaging in patients with angioimmunoblastic T-cell lymphoma
por: Gong, Huanyu, et al.
Publicado: (2021)

Prognostic value of metabolic tumor volume and total lesion glycolysis from (18)F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma
por: Liu, Dou-dou, et al.
Publicado: (2019)

Significance of initial, interim and end-of-therapy (18)F-FDG PET/CT for predicting transformation risk in follicular lymphoma
por: Xie, Mixue, et al.
Publicado: (2021)

Diagnostic value of baseline (18)FDG PET/CT skeletal textural features in follicular lymphoma
por: Faudemer, Julie, et al.
Publicado: (2021)

Prognostic value of baseline, interim and end-of-treatment (18)F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis
por: Wang, Hongxi, et al.
Publicado: (2018)

Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review
por: Adams, Hugo J. A., et al.
Publicado: (2015)

Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma
por: Kanoun, Salim, et al.
Publicado: (2015)

Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients
por: Czibor, Sándor, et al.
Publicado: (2023)

Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using (18)F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma
por: Chun, You Jin, et al.
Publicado: (2019)

Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments
por: Jemaa, S., et al.
Publicado: (2022)

Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative (18)F-FDG PET/CT in patients with localized primary gastrointestinal stromal tumors
por: Hwang, Sang Hyun, et al.
Publicado: (2021)

Prognostic values of interim and post-therapy (18)F-FDG PET/CT scanning in adult patients with Burkitt’s lymphoma
por: Wei, Wen-Xiao, et al.
Publicado: (2015)

Repeatability of [(18)F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
por: Kolinger, Guilherme D., et al.
Publicado: (2019)

Total Lesion Glycolysis Using (18)F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer
por: Hong, Ji Hyung, et al.
Publicado: (2016)

Quantification of pulmonary disease activity in sarcoidosis measured with (18)F-FDG PET/CT: SUVmax versus total lung glycolysis
por: Schimmelpennink, Milou C., et al.
Publicado: (2019)

Healthy Organs Uptake on Baseline (18)F-FDG PET/CT as an Alternative to Total Metabolic Tumor Volume to Predict Event-Free Survival in Classical Hodgkin's Lymphoma
por: Morland, David, et al.
Publicado: (2022)

Utility of baseline, interim and end-of-treatment (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase
por: Chang, Yu, et al.
Publicado: (2017)

FDG-PET in Follicular Lymphoma Management
por: Bodet-Milin, C., et al.
Publicado: (2012)

Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis
por: Guo, Baoping, et al.
Publicado: (2019)

Baseline total lesion glycolysis combined with interim positron emission tomography‐computed tomography is a robust predictor of outcome in patients with peripheral T‐cell lymphoma
por: Kitadate, Akihiro, et al.
Publicado: (2020)

Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET/CT
por: Li, Hongyan, et al.
Publicado: (2022)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
por: André, M., et al.
Publicado: (2011)

Prognostic value of maximum standard uptake value, metabolic tumour volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with malignant pleural mesothelioma: a systematic review and meta-analysis
por: Wen, Weibo, et al.
Publicado: (2022)

(18)F-FDG-PET uptake in non-infected total hip prostheses
por: Gelderman, Stefan J, et al.
Publicado: (2018)

Predictive value of baseline (18)F-FDG PET/CT and interim treatment response for the prognosis of patients with diffuse large B-cell lymphoma receiving R-CHOP chemotherapy
por: Zhu, Lili, et al.
Publicado: (2021)

Total lesion glycolysis on FDG-PET/CT before salvage surgery predicts survival in laryngeal or pharyngeal cancer
por: Suzuki, Hidenori, et al.
Publicado: (2018)

Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2022)

Pediatric Hodgkin Lymphoma: Predictive value of interim (18)F-FDG PET/CT in therapy response assessment
por: Ferrari, Cristina, et al.
Publicado: (2017)

(18)F-FDG PET/CT total lesion glycolysis is associated with circulating tumor cell counts in patients with stage I to IIIA non-small cell lung cancer
por: Avella, Diego M., et al.
Publicado: (2020)

Expression of Concern: Prognostic value of baseline, interim and end-of-treatment (18)F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis
Publicado: (2023)

Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low (18)F-FDG Activity
por: Hu, Yan, et al.
Publicado: (2022)

Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma
por: Park, Hye Lim, et al.
Publicado: (2020)

Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of (18)F-FDG PET/CT in patients with renal carcinoma: A protocol for systematic review and meta analysis
por: Xuan, Dongchun, et al.
Publicado: (2020)

Prognostic Impact of Total Lesion Glycolysis (TLG) from Preoperative (18)F-FDG PET/CT in Stage II/III Colorectal Adenocarcinoma: Extending the Value of PET/CT for Resectable Disease
por: Lee, Sea-Won, et al.
Publicado: (2022)

A proper protocol for routine (18)F-FDG uEXPLORER total-body PET/CT scans
por: Hu, Huiran, et al.
Publicado: (2023)

Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma
por: Rogasch, Julian M. M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_17ag8noopleg293ottpgepoj5t